Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Other Non-Current Assets (2016 - 2025)

Lisata Therapeutics (LSTA) has disclosed Other Non-Current Assets for 12 consecutive years, with $23000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Non-Current Assets fell 88.56% year-over-year to $23000.0, compared with a TTM value of $23000.0 through Sep 2025, down 88.56%, and an annual FY2024 reading of $160000.0, down 51.81% over the prior year.
  • Other Non-Current Assets was $23000.0 for Q3 2025 at Lisata Therapeutics, down from $70000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $449000.0 in Q1 2023 and bottomed at $23000.0 in Q3 2025.
  • Average Other Non-Current Assets over 3 years is $242545.5, with a median of $246000.0 recorded in 2024.
  • The sharpest move saw Other Non-Current Assets crashed 35.41% in 2024, then tumbled 88.56% in 2025.
  • Year by year, Other Non-Current Assets stood at $332000.0 in 2023, then plummeted by 51.81% to $160000.0 in 2024, then tumbled by 85.62% to $23000.0 in 2025.
  • Business Quant data shows Other Non-Current Assets for LSTA at $23000.0 in Q3 2025, $70000.0 in Q2 2025, and $116000.0 in Q1 2025.